# Nausea on Ozempic, Wegovy, Mounjaro or Zepbound · PepVault

Source: https://pepvault.app/guides/nausea-on-a-glp-1

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Nausea on Ozempic, Wegovy, Mounjaro or Zepbound: when it peaks and what helps

Reviewed November 2026 11 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Nausea on Ozempic, Wegovy, Mounjaro and Zepbound: each label's rate by dose against placebo, the week it peaks, how long a bout lasts and what helps.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 11
- **Questions:** 8
- **Compounds:** 3

## The short answer

Nausea is the most common side effect of all four. In the weight trials it hit 44% on Wegovy 2.4 mg and 25% to 29% on Zepbound, against 16% and 8% on placebo. On semaglutide it peaked around week 20, just after the dose climb, and a bout lasted a median of 8 days. Small, plain, low-fat meals, eaten slowly, and steady sips of fluid help.

Every number checked at its primary source · Nov 20, 2026 · [11 sources](https://pepvault.app/guides/nausea-on-a-glp-1#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** FDA prescribing information for all four medicines, built on randomized placebo-controlled trials in people; trial registry results from STEP 1, SURMOUNT-1 and SURMOUNT-5; two sponsor-funded analyses of the trials after the fact for timing and duration; an expert consensus and a joint society advisory for the eating advice.

## How common is nausea on Ozempic, Wegovy, Mounjaro and Zepbound?

The most common side effect on all four. Ozempic and Wegovy are semaglutide; Mounjaro and Zepbound are tirzepatide. Each US label counts the share of people in its placebo-controlled trials who reported nausea or vomiting at least once, beside a placebo group on a dummy shot[1](https://pepvault.app/guides/nausea-on-a-glp-1#source-1) [2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2) [3](https://pepvault.app/guides/nausea-on-a-glp-1#source-3) [4](https://pepvault.app/guides/nausea-on-a-glp-1#source-4):

| Medicine and dose | Trials behind the number | Nausea: drug / placebo | Vomiting: drug / placebo |
| --- | --- | --- | --- |
| Ozempic 0.5 mg | 2 type 2 diabetes trials, 32.9 weeks on average | 15.8% / 6.1% | 5% / 2.3% |
| Ozempic 1 mg | The same 2 trials | 20.3% / 6.1% | 9.2% / 2.3% |
| Mounjaro 5 mg | 2 type 2 diabetes trials, 36.6 weeks on average | 12% / 4% | 5% / 2% |
| Mounjaro 10 mg | The same 2 trials | 15% / 4% | 5% / 2% |
| Mounjaro 15 mg | The same 2 trials | 18% / 4% | 9% / 2% |
| Wegovy 2.4 mg | 3 weight trials, up to 68 weeks | 44% / 16% | 24% / 6% |
| Wegovy 7.2 mg | 2 weight trials, 72 weeks | 39% / 13% | 22% / 6% |
| Zepbound 5 mg | 2 weight trials, up to 72 weeks | 25% / 8% | 8% / 2% |
| Zepbound 10 mg | The same 2 trials | 29% / 8% | 11% / 2% |
| Zepbound 15 mg | The same 2 trials | 28% / 8% | 13% / 2% |

The gap between drug and placebo is the part the medicine adds. The weight doses bring more nausea than the diabetes doses, and the labels warn that rates from different trials cannot be compared directly[1](https://pepvault.app/guides/nausea-on-a-glp-1#source-1) [3](https://pepvault.app/guides/nausea-on-a-glp-1#source-3). In the 7.2 mg trials, the 2.4 mg group reported nausea at 35%[2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2). When both drugs ran in one 72-week trial (SURMOUNT-5) at their top weight doses or the highest tolerated, nausea was a tie, 43.6% on tirzepatide and 44.4% on semaglutide, while vomiting was lower on tirzepatide, 15.0% against 21.3%[11](https://pepvault.app/guides/nausea-on-a-glp-1#source-11).

In teenagers aged 12 and older on Wegovy 2.4 mg, nausea affected 42% against 18% on placebo, and vomiting 36% against 10%[2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2).

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's dose log keeps each weekly shot with its date and the step-ups your prescriber set, as you enter them, so a queasy week can be matched to the step before it.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## When does GLP-1 nausea peak?

During and just after the dose climb, called titration: the step-up from a low starting dose every four weeks or more. All four labels say most nausea, vomiting and diarrhea came while the dose was rising, and the Mounjaro and Zepbound labels add that it decreased over time[1](https://pepvault.app/guides/nausea-on-a-glp-1#source-1) [2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2) [3](https://pepvault.app/guides/nausea-on-a-glp-1#source-3) [4](https://pepvault.app/guides/nausea-on-a-glp-1#source-4).

| Weeks on semaglutide 2.4 mg (STEP 1 to 3) | Dose | What the trials saw |
| --- | --- | --- |
| 1 to 16 | 0.25, 0.5, 1 and 1.7 mg, four weeks each | Most people who had a stomach side effect had their first one during the climb[5](https://pepvault.app/guides/nausea-on-a-glp-1#source-5). |
| 17 | 2.4 mg | The climb reaches the full dose[2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2). |
| About 20 | 2.4 mg | The share of people with nausea at any one time peaks; after week 20, few have a first stomach side effect[5](https://pepvault.app/guides/nausea-on-a-glp-1#source-5). |
| 20 to 68 | 2.4 mg | Nausea falls the most of any stomach effect, while staying above placebo[5](https://pepvault.app/guides/nausea-on-a-glp-1#source-5). |

On tirzepatide the climb is longer: 2.5 mg for four weeks, then 2.5 mg more every four weeks or more, so 15 mg arrives at week 20 at the earliest[4](https://pepvault.app/guides/nausea-on-a-glp-1#source-4). The pattern is the same. In SURMOUNT-1 to -3, people who needed an anti-nausea medicine most often took their first one in the first 24 weeks, the stretch that held the climb[6](https://pepvault.app/guides/nausea-on-a-glp-1#source-6). An expert panel puts the most nausea in the first four to five weeks, when stomach emptying slows the most[7](https://pepvault.app/guides/nausea-on-a-glp-1#source-7).

<!--promo-->

PepVault's dose log keeps each weekly shot with its date and the step-ups your prescriber set, as you enter them, so a queasy week can be matched to the step before it. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-nausea-on-a-glp-1-inline&mt=8)

<!--/promo-->

## Which day after the shot is nausea worst?

No trial we found counted nausea by day of the week; what is known is how the drugs move through the blood. Semaglutide reaches its highest level 1 to 3 days after a shot; tirzepatide reaches its peak after a median of 24 hours, anywhere from 8 to 72 hours[2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2) [4](https://pepvault.app/guides/nausea-on-a-glp-1#source-4).

A 2025 advisory from four US obesity and nutrition societies says nausea often comes in the morning or after a long stretch without food, and that some people get caught in a loop: they skip food because they feel sick, which makes the nausea worse[8](https://pepvault.app/guides/nausea-on-a-glp-1#source-8).

**Commonly reported:** queasiness worst in the first one to three days after the shot and in the weeks after a step-up, easing by the next dose. Nausea or an upset stomach was mentioned by 14 of 41 people on semaglutide and 9 of 77 on tirzepatide in the open write-ups counted on our reports pages.

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)
- [Constipation on Ozempic, Mounjaro or Zepbound: how common, and what helps](https://pepvault.app/guides/constipation-on-a-glp-1)
- [Headaches on a GLP-1: how common they were in the trials](https://pepvault.app/guides/headaches-on-a-glp-1)
- [Sulfur burps on Ozempic or Mounjaro: why they happen](https://pepvault.app/guides/sulfur-burps-on-a-glp-1)
- [GLP-1s and the gallbladder: gallstones, and taking one without a gallbladder](https://pepvault.app/guides/glp-1s-and-the-gallbladder)
- [GLP-1s and the heart: heart rate, blood pressure and the SELECT trial](https://pepvault.app/guides/glp-1s-and-the-heart)
- [Do GLP-1s cause cancer? The thyroid warning and what the studies show](https://pepvault.app/guides/do-glp-1s-cause-cancer)
- [Retatrutide and cancer: what the warning and the studies say](https://pepvault.app/guides/retatrutide-and-cancer)
- [Retatrutide and muscle loss: what the studies measured](https://pepvault.app/guides/retatrutide-and-muscle)

### Terms on this page

- [Titration](https://pepvault.app/glossary/titration)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)

## How long does nausea last on a GLP-1?

About a week per bout. In the pooled STEP 1 to 3 trials each episode was timed from start to end: the median, the middle value, was 8 days for nausea and 2 days for vomiting on semaglutide 2.4 mg, similar to placebo[5](https://pepvault.app/guides/nausea-on-a-glp-1#source-5). The trial registries count every bout reported, so we divided those counts by the number of people who had any[9](https://pepvault.app/guides/nausea-on-a-glp-1#source-9) [10](https://pepvault.app/guides/nausea-on-a-glp-1#source-10) [11](https://pepvault.app/guides/nausea-on-a-glp-1#source-11):

| Trial and group | People with nausea | Bouts reported | Bouts per person who had it (our division) |
| --- | --- | --- | --- |
| STEP 1, semaglutide 2.4 mg (to week 75) | 576 of 1,306 (44.1%) | 1,067 | 1.9 |
| STEP 1, placebo | 114 of 655 (17.4%) | 146 | 1.3 |
| SURMOUNT-1, tirzepatide 5 mg (up to 193 weeks) | 160 of 630 (25.4%) | 404 | 2.5 |
| SURMOUNT-1, tirzepatide 10 mg | 217 of 636 (34.1%) | 540 | 2.5 |
| SURMOUNT-1, tirzepatide 15 mg | 201 of 630 (31.9%) | 506 | 2.5 |
| SURMOUNT-1, placebo | 63 of 643 (9.8%) | 103 | 1.6 |
| SURMOUNT-5, tirzepatide (72 weeks) | 163 of 374 (43.6%) | 561 | 3.4 |
| SURMOUNT-5, semaglutide | 167 of 376 (44.4%) | 505 | 3.0 |

So people who felt sick had two to three bouts on average over a year or more, against 1.3 to 1.6 on placebo, each lasting days. Read each trial on its own: SURMOUNT-1's count runs to week 193, and SURMOUNT-5 was open-label, so everyone knew which drug they took[10](https://pepvault.app/guides/nausea-on-a-glp-1#source-10) [11](https://pepvault.app/guides/nausea-on-a-glp-1#source-11). After the climb it keeps easing: in STEP 4, people who reached 2.4 mg by week 20 and stayed on it saw nausea fall over the next 48 weeks, and only two stopped for a stomach effect after week 20[5](https://pepvault.app/guides/nausea-on-a-glp-1#source-5). No primary source we found gives a per-bout length for tirzepatide.

## Why do GLP-1s make you nauseous?

Two things at once. GLP-1 medicines slow stomach emptying, so food sits longer, and all four labels state that effect[1](https://pepvault.app/guides/nausea-on-a-glp-1#source-1) [2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2) [3](https://pepvault.app/guides/nausea-on-a-glp-1#source-3) [4](https://pepvault.app/guides/nausea-on-a-glp-1#source-4). They also act on the brain: the STEP analysis's authors write that GLP-1 nausea may come mainly from the brain, because in animal studies the nausea from GLP-1 shots runs through GLP-1 receptors in the central nervous system[5](https://pepvault.app/guides/nausea-on-a-glp-1#source-5). That part is an animal finding.

Nausea is not the engine of the weight loss. Of the extra weight lost on semaglutide 2.4 mg over placebo, under one percentage point was explained by stomach side effects[5](https://pepvault.app/guides/nausea-on-a-glp-1#source-5). For tirzepatide, nausea, vomiting, diarrhea and indigestion together accounted for up to 3.1% of the weight lost, and people with nausea lost slightly more, not less: 22.0% against 19.7% in SURMOUNT-1[6](https://pepvault.app/guides/nausea-on-a-glp-1#source-6). A settled stomach does not mean the dose has stopped working.

## Is nausea on a GLP-1 serious?

Almost never. In STEP 1 to 3, 98.1% of all stomach side effects on semaglutide 2.4 mg were mild or moderate and 99.5% were not serious[5](https://pepvault.app/guides/nausea-on-a-glp-1#source-5). In STEP 1, one person of 1,306 on semaglutide had nausea counted as a serious event, and four had vomiting[9](https://pepvault.app/guides/nausea-on-a-glp-1#source-9). Few stopped: on Wegovy, 1.8% left over nausea and 1.2% over vomiting, against 0.2% and 0% on placebo[2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2). More often the dose was adjusted: 12.5% on semaglutide lowered or paused it for a stomach effect, against 1.7% on placebo[5](https://pepvault.app/guides/nausea-on-a-glp-1#source-5).

The real risk is fluid. All four labels note that kidney injury has been reported after approval, mostly in people whose nausea, vomiting or diarrhea dried them out, and they ask people to drink enough[1](https://pepvault.app/guides/nausea-on-a-glp-1#source-1) [2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2) [3](https://pepvault.app/guides/nausea-on-a-glp-1#source-3) [4](https://pepvault.app/guides/nausea-on-a-glp-1#source-4).

## What helps with nausea on a GLP-1?

Small, plain meals and steady fluids. The steps below come from the expert panel's list for nausea and vomiting, the nutrition advisory and the trials' own counselling[6](https://pepvault.app/guides/nausea-on-a-glp-1#source-6) [7](https://pepvault.app/guides/nausea-on-a-glp-1#source-7) [8](https://pepvault.app/guides/nausea-on-a-glp-1#source-8):

1. Eat a small breakfast, then small meals every three to four hours, so your stomach is never empty for long and never overfull.
2. Eat slowly, and stop at the first sign of fullness, even with food left on the plate.
3. Choose bland, low-fat food cooked by baking, grilling or boiling; skip fried food, rich sauces and very sweet meals.
4. Keep crackers, apples, mint or ginger at hand; ginger or peppermint tea, and acupressure wristbands, help some people.
5. Sip clear, cool drinks through the day, and if nausea lingers, drink 30 to 60 minutes before or after a meal rather than with it.
6. Stay upright after eating, avoid strong smells, and get some fresh air or a light walk.
7. Keep alcohol to a minimum: the advisory says it can worsen nausea and reflux.

If that is not enough, the dose and a medicine are your prescriber's levers. The Wegovy shot's label tells prescribers to consider waiting four more weeks before the next step if a dose is not tolerated[2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2). Anti-nausea medicines were common: 13.8% to 27.5% of people on tirzepatide in SURMOUNT-1 to -3 used one, against 5.8% to 6.7% on placebo[6](https://pepvault.app/guides/nausea-on-a-glp-1#source-6). The advisory notes that some, such as prochlorperazine, may suit better than ondansetron, which can worsen constipation[8](https://pepvault.app/guides/nausea-on-a-glp-1#source-8), and the panel suggests a lower dose if one is still needed a month after reaching the full dose[7](https://pepvault.app/guides/nausea-on-a-glp-1#source-7). None of these is approved for GLP-1 nausea itself; our guide to tradipitant covers the one with a phase 3 result.

**When to get help** Tell your prescriber promptly about nausea or vomiting that is severe or will not go away; stop the shot and call right away for severe pain in your stomach area that will not go away, with or without vomiting, as the labels ask[1](https://pepvault.app/guides/nausea-on-a-glp-1#source-1) [2](https://pepvault.app/guides/nausea-on-a-glp-1#source-2) [3](https://pepvault.app/guides/nausea-on-a-glp-1#source-3) [4](https://pepvault.app/guides/nausea-on-a-glp-1#source-4).

## How do I keep track of nausea on a GLP-1?

Note the day it starts, how strong it is, what you ate and your dose. A few weeks of notes show whether it fades after each step-up, as in the trials, or keeps going, the pattern to bring to your prescriber.

<!--promo-->

PepVault's side-effect log records each symptom with the compound, a severity from minimal to very severe, the date and a note. Nausea is one tap in the quick list. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-nausea-on-a-glp-1-inline&mt=8)

<!--/promo-->

Diarrhea, constipation and heartburn on a GLP-1 have their own guides.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. OZEMPIC (semaglutide) injection prescribing information, DailyMed (SPL version 20; published on DailyMed June 10, 2026). Sections 5.6, 6.1 (Table 1), 12.3, 17 and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
2. WEGOVY (semaglutide) injection and tablets prescribing information, DailyMed (SPL version 19; published on DailyMed June 30, 2026). Sections 2.2, 5, 6.1 (Tables 3, 4 and 5), 12.3, 17 and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3. MOUNJARO (tirzepatide) injection prescribing information, DailyMed (SPL version 40; published on DailyMed September 2, 2026). Sections 5, 6.1 (Table 1), 12.3, 17 and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
4. ZEPBOUND (tirzepatide) injection prescribing information, DailyMed (SPL version 40; published on DailyMed September 2, 2026). Sections 2, 5, 6.1 (Table 1), 12.3, 17 and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
5. Wharton S et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24:94-105. [PubMed 34514682](https://pubmed.ncbi.nlm.nih.gov/34514682/)
6. Rubino DM et al. Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials. Diabetes Obes Metab. 2025;27:1826-1835. [PubMed 39789843](https://pubmed.ncbi.nlm.nih.gov/39789843/)
7. Gorgojo-Martínez JJ et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med. 2023;12:145. [PubMed 36614945](https://pubmed.ncbi.nlm.nih.gov/36614945/)
8. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. Obesity (Silver Spring). 2025;33(8):1475-1503. [PubMed 40445127](https://pubmed.ncbi.nlm.nih.gov/40445127/)
9. ClinicalTrials.gov NCT03548935 (STEP 1; sponsor Novo Nordisk A/S). Results: adverse events, week 0 to 75. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03548935)
10. ClinicalTrials.gov NCT04184622 (SURMOUNT-1; sponsor Eli Lilly and Company). Results: adverse events, baseline up to week 193. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04184622)
11. ClinicalTrials.gov NCT05822830 (SURMOUNT-5; sponsor Eli Lilly and Company). Results: adverse events, baseline up to week 72. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05822830)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Headaches on a GLP-1: how common they were in the trials](https://pepvault.app/guides/headaches-on-a-glp-1)

Headache hit 14% on Wegovy vs 10% on placebo, while tirzepatide's trials matched placebo. Every label and trial side by side, why it happens and what helps.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Semaglutide (oral) Studied range: 1.5–25 mg](https://pepvault.app/peptides/semaglutide-oral)

## Related guides

- Guide · GLP-1s

  ### [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)

  No medicine is approved for GLP-1 nausea yet. Tradipitant, a motion-sickness pill, cut vomiting after semaglutide in phase 3. What it does, and what helps now.

  Read the guide
- Guide · GLP-1s

  ### [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)

  Ozempic and Wegovy side effects from the labels' trials, drug against placebo: nausea and the rest, when they start, how many days they last, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)

  Mounjaro and Zepbound side effects at 5, 10 and 15 mg against placebo, from the labels' trial tables: when they show up, how many stopped, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)

  Semaglutide vs tirzepatide side effects in the same trials: nausea, vomiting, reflux, hair loss and injection-site rates side by side, and how many stopped.

  Read the guide
- Guide · GLP-1s

  ### [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)

  Diarrhea on Ozempic, Wegovy, Mounjaro and Zepbound: each label's rate by dose against placebo, when it starts, how long a bout lasts, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Constipation on Ozempic, Mounjaro or Zepbound: how common, and what helps](https://pepvault.app/guides/constipation-on-a-glp-1)

  Constipation on Ozempic, Wegovy, Mounjaro and Zepbound: each label's rate against placebo, when it starts, why it lasts for weeks, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)

  Heartburn and acid reflux on Ozempic, Wegovy, Mounjaro and Zepbound: the four labels' rates against placebo, when it shows up, what helps and when to call.

  Read the guide
- Guide · GLP-1s

  ### [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)

  What to eat on Ozempic, Wegovy or Zepbound: protein first, small regular meals, fiber and fluids, what to limit, and what the trials' diet programmes asked for.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)
- [Constipation on Ozempic, Mounjaro or Zepbound: how common, and what helps](https://pepvault.app/guides/constipation-on-a-glp-1)
- [Headaches on a GLP-1: how common they were in the trials](https://pepvault.app/guides/headaches-on-a-glp-1)
- [Sulfur burps on Ozempic or Mounjaro: why they happen](https://pepvault.app/guides/sulfur-burps-on-a-glp-1)
- [GLP-1s and the gallbladder: gallstones, and taking one without a gallbladder](https://pepvault.app/guides/glp-1s-and-the-gallbladder)
- [GLP-1s and the heart: heart rate, blood pressure and the SELECT trial](https://pepvault.app/guides/glp-1s-and-the-heart)
- [Do GLP-1s cause cancer? The thyroid warning and what the studies show](https://pepvault.app/guides/do-glp-1s-cause-cancer)
- [Retatrutide and cancer: what the warning and the studies say](https://pepvault.app/guides/retatrutide-and-cancer)
- [Retatrutide and muscle loss: what the studies measured](https://pepvault.app/guides/retatrutide-and-muscle)

### Terms on this page

- [Titration](https://pepvault.app/glossary/titration)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
